TrialAmerican journal of respiratory and critical care medicine2023

An Inhaled Galectin-3 Inhibitor in COVID-19 Pneumonitis: A Phase Ib/IIa Randomized Controlled Clinical Trial (DEFINE).

Erin E Gaughan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.